Report’s Key Features
• PDF with > 430+ slides
• Identification & mapping of the startups that recently started to work in the field of cancer diagostics.
• Identification & mapping of the startups that recently started to work in the field of cancer diagnostics.
• Segmentation by technology (Medical imaging, Software, AI-based tool, Biochemical analysis, Molecular diagnostics, Lab-on-chip, Liquid biopsy etc.)
• Description of the startups and their current stage of product development, funding rounds and subsidies.
• Presentation of all their relevant published patent families.
• Description of key people and their background.
Report’s Key Features
• PDF with > 310+ slides
• Identification of the startups that recently started to work in the field of Microfluidics
• Mapping of the new startups
• Segmentation by technology and application
• Focused analysis of the projects aiming at Oncology, Diabetes and Neurology.
• Description of the startups and their microfluidic-related projects
• Presentation of all their published patent families.
• Description of key people and their background.
• Excel database containing all patents analyzed in the report
Report’s Key Features
• PDF with > 280+ slides
• Identification & mapping of the startups that recently started to work in the field of Onco-Immunotherapy.
• Segmentation by technology (Immune check point inhibitor, Adoptive cell transfer, Bispecific antibody, Vaccine etc.)
• Description of the startups and their pipeline, funding rounds and subsidies.
• Presentation of all their published patent families.
• Description of key people and their background.
Artifical intelligence in medical diagnostics 2019 patent landscape sampleKnowmade
Report’s Key Features
• PDF >170 slides
• Excel file >22,600 patents
• IP trends, including time-evolution of published patents, and countries of patent filings
• Ranking of main patent assignees
• Identifications of over 90 start-up firms and IP newcomers
• Summary of the IP related to the medical exams: ECG, EEG, EMG, MRI, CT scan, PET scan, facial analysis, speech analysis, OCT, etc.
• Summary of the IP related to the clinical areas involved: Cardiology, Oncology, Diabetes, Osteology, etc.
• Key patents & main litigations analysis
• Excel database containing all patents analyzed in this report, including technology and application segmentations
Artifical intelligence in medical diagnostics 2019 patent landscape flyerKnowmade
Report’s Key Features
• PDF >170 slides
• Excel file >22,600 patents
• IP trends, including time-evolution of published patents, and countries of patent filings
• Ranking of main patent assignees
• Identifications of over 90 start-up firms and IP newcomers
• Summary of the IP related to the medical exams: ECG, EEG, EMG, MRI, CT scan, PET scan, facial analysis, speech analysis, OCT, etc.
• Summary of the IP related to the clinical areas involved: Cardiology, Oncology, Diabetes, Osteology, etc.
• Key patents & main litigations analysis
• Excel database containing all patents analyzed in this report, including technology and application segmentations
This document provides a summary of a patent landscape analysis report on nanopore sequencing technologies. The analysis found that patent publications on nanopore sequencing have significantly increased from 2008-2013, following early work proving the concept. While industrial players are increasingly active, Harvard University's portfolio remains the strongest, followed by Illumina, Agilent, University of California, and Roche. Oxford Nanopore Technologies' portfolio is not the strongest but the company benefits from university partnerships. Several microelectronics companies have also recently filed solid-state nanopore patents. Most major assignees have an international IP strategy with a strong US and European presence. The report provides a detailed analysis of patents segmented by nanopore technology and application, as well as profiles of key
Microneedles for drug delivery patent landscape 2020 flyerKnowmade
Report’s Key Features
• PDF with > 140 slides
• Excel file > 2,450 patent families
• IP trends, including time-evolution of published patents, and countries of patent filings
• Patents’ legal status
• Ranking of main patent assignees
• Key players’ IP position and relative strength of their patent portfolios
• Summary of the IP related to applications: Cancer therapy, Cosmetic, Diabetes, Ophthalmic, Pain management and Vaccine.
• Summary of the IP related to technologies: Applicators, housing, Coated, Hollow, Porous, Soluble, Hydrogel and Solid microneedles.
• Analysis of patent oppositions (Europe) and review of key patents.
• Excel database containing all patents analyzed in the report, including applications and technologies segmentations
Report’s Key Features
• PDF with > 160 slides
• Excel file > 5,500 patents
• IP trends, including time-evolution of published patents, and countries of patent filings
• Patents’ legal status
• Ranking of main patent assignees
• Key players’ IP position and relative strength of their patent portfolios
• Summary of the IP related to the physical isolation: size, deformability, electrical charges or density.
• Summary of the IP related to the biological isolation: positive or negative enrichment.
• Summary of the IP related to the CTC detection: nucleic acid, protein or functional assay.
• Analysis of patent litigations and review of key patents.
• Excel database containing all patents analyzed in the report, including biological and physical isolation and detection segmentations
Report’s Key Features
• PDF with > 280+ slides
• Identification & mapping of the startups that recently started to work in the field of Onco-Immunotherapy.
• Segmentation by technology (Immune check point inhibitor, Adoptive cell transfer, Bispecific antibody, Vaccine etc.)
• Description of the startups and their pipeline, funding rounds and subsidies.
• Presentation of all their published patent families.
• Description of key people and their background.
Report’s Key Features
• PDF with > 310+ slides
• Identification of the startups that recently started to work in the field of Microfluidics
• Mapping of the new startups
• Segmentation by technology and application
• Focused analysis of the projects aiming at Oncology, Diabetes and Neurology.
• Description of the startups and their microfluidic-related projects
• Presentation of all their published patent families.
• Description of key people and their background.
• Excel database containing all patents analyzed in the report
Report’s Key Features
• PDF with > 280+ slides
• Identification & mapping of the startups that recently started to work in the field of Onco-Immunotherapy.
• Segmentation by technology (Immune check point inhibitor, Adoptive cell transfer, Bispecific antibody, Vaccine etc.)
• Description of the startups and their pipeline, funding rounds and subsidies.
• Presentation of all their published patent families.
• Description of key people and their background.
Artifical intelligence in medical diagnostics 2019 patent landscape sampleKnowmade
Report’s Key Features
• PDF >170 slides
• Excel file >22,600 patents
• IP trends, including time-evolution of published patents, and countries of patent filings
• Ranking of main patent assignees
• Identifications of over 90 start-up firms and IP newcomers
• Summary of the IP related to the medical exams: ECG, EEG, EMG, MRI, CT scan, PET scan, facial analysis, speech analysis, OCT, etc.
• Summary of the IP related to the clinical areas involved: Cardiology, Oncology, Diabetes, Osteology, etc.
• Key patents & main litigations analysis
• Excel database containing all patents analyzed in this report, including technology and application segmentations
Artifical intelligence in medical diagnostics 2019 patent landscape flyerKnowmade
Report’s Key Features
• PDF >170 slides
• Excel file >22,600 patents
• IP trends, including time-evolution of published patents, and countries of patent filings
• Ranking of main patent assignees
• Identifications of over 90 start-up firms and IP newcomers
• Summary of the IP related to the medical exams: ECG, EEG, EMG, MRI, CT scan, PET scan, facial analysis, speech analysis, OCT, etc.
• Summary of the IP related to the clinical areas involved: Cardiology, Oncology, Diabetes, Osteology, etc.
• Key patents & main litigations analysis
• Excel database containing all patents analyzed in this report, including technology and application segmentations
This document provides a summary of a patent landscape analysis report on nanopore sequencing technologies. The analysis found that patent publications on nanopore sequencing have significantly increased from 2008-2013, following early work proving the concept. While industrial players are increasingly active, Harvard University's portfolio remains the strongest, followed by Illumina, Agilent, University of California, and Roche. Oxford Nanopore Technologies' portfolio is not the strongest but the company benefits from university partnerships. Several microelectronics companies have also recently filed solid-state nanopore patents. Most major assignees have an international IP strategy with a strong US and European presence. The report provides a detailed analysis of patents segmented by nanopore technology and application, as well as profiles of key
Microneedles for drug delivery patent landscape 2020 flyerKnowmade
Report’s Key Features
• PDF with > 140 slides
• Excel file > 2,450 patent families
• IP trends, including time-evolution of published patents, and countries of patent filings
• Patents’ legal status
• Ranking of main patent assignees
• Key players’ IP position and relative strength of their patent portfolios
• Summary of the IP related to applications: Cancer therapy, Cosmetic, Diabetes, Ophthalmic, Pain management and Vaccine.
• Summary of the IP related to technologies: Applicators, housing, Coated, Hollow, Porous, Soluble, Hydrogel and Solid microneedles.
• Analysis of patent oppositions (Europe) and review of key patents.
• Excel database containing all patents analyzed in the report, including applications and technologies segmentations
Report’s Key Features
• PDF with > 160 slides
• Excel file > 5,500 patents
• IP trends, including time-evolution of published patents, and countries of patent filings
• Patents’ legal status
• Ranking of main patent assignees
• Key players’ IP position and relative strength of their patent portfolios
• Summary of the IP related to the physical isolation: size, deformability, electrical charges or density.
• Summary of the IP related to the biological isolation: positive or negative enrichment.
• Summary of the IP related to the CTC detection: nucleic acid, protein or functional assay.
• Analysis of patent litigations and review of key patents.
• Excel database containing all patents analyzed in the report, including biological and physical isolation and detection segmentations
Report’s Key Features
• PDF with > 280+ slides
• Identification & mapping of the startups that recently started to work in the field of Onco-Immunotherapy.
• Segmentation by technology (Immune check point inhibitor, Adoptive cell transfer, Bispecific antibody, Vaccine etc.)
• Description of the startups and their pipeline, funding rounds and subsidies.
• Presentation of all their published patent families.
• Description of key people and their background.
Cancer diagnostics startup identification 2020 sampleKnowmade
Report’s Key Features
• PDF with > 430+ slides
• Identification & mapping of the startups that recently started to work in the field of cancer diagostics.
• Identification & mapping of the startups that recently started to work in the field of cancer diagnostics.
• Segmentation by technology (Medical imaging, Software, AI-based tool, Biochemical analysis, Molecular diagnostics, Lab-on-chip, Liquid biopsy etc.)
• Description of the startups and their current stage of product development, funding rounds and subsidies.
• Presentation of all their relevant published patent families.
• Description of key people and their background.
Antenna for 5G patent landscape 2019 flyerKnowmade
Report’s Key Features
• PDF >120 slides
• Excel file >3,600 patents
• IP trends, including time-evolution of published patents, and countries of patent filings
• Ranking of main patent assignees
• Patent analysis for main applications (handsets, infrastructures & networks, vehicles) and technologies (MIMO, beamforming, antenna array, mm-wave, monopole antenna, dipole antenna, microstrip antenna, etc.)
• Key patents
• Key players’ IP position, and relative strength of their patent portfolios
• Key players’ IP profile: Samsung Electronics, Oppo Mobile, Huawei, and Intel
• Excel database containing all patents analyzed in this report, including technology and application segmentations
Report’s Key Features
• PDF with > 310+ slides
• Identification of the startups that recently started to work in the field of Microfluidics
• Mapping of the new startups
• Segmentation by technology and application
• Focused analysis of the projects aiming at Oncology, Diabetes and Neurology.
• Description of the startups and their microfluidic-related projects
• Presentation of all their published patent families.
• Description of key people and their background.
• Excel database containing all patents analyzed in the report
Report’s Key Features
• PDF with > 200 slides
• Excel file > 2,500 patents
• IP trends, including time-evolution of published patents, countries of patent filings, etc.
• Patent segmentation per application: Optoelectronics and Photonics, Power, RF, PV and Sensors
• Ranking of main patent assignees
• Key players’ IP position and relative strength of their patent portfolios
• Established players and new entrants
• IP profile of key players, their key patents and their recent IP activity
• Patents recently expired and patents near expiration date
• Excel database containing all patents analyzed in the report, including technology and application segmentations
Solid electrolytes for lithium ion solid state batteries patent landscape 201...Knowmade
Report’s Key Features
• PDF with > 250 slides
• Excel file > 5,800 patents
• IP trends, including time-evolution of published patents, legal status, countries of patent filings, etc.
• Ranking of main patent assignees
• Patent categorization by type of electrolyte (polymer, inorganic, inorganic/polymer) and inorganic electrolyte materials (sulfide glass ceramics, Thio-LISICON, argyrodite, oxide glass ceramics, NASICON, perovskite, garnet, anti-perovskite, hydride)
• For each technical segment: IP dynamics, ranking of main patent assignees, newcomers, key IP players (leadership, blocking potential, portfolio strength), key patents, and recent development trends
• For each key IP player (100+ companies): Time-evolution of patenting activity, legal status of patents and countries of patent filings, patent segmentation by electrolyte material, IP strengths and weaknesses by electrolyte material
• Excel database containing all patents analyzed in this report, including technology and material segmentations
Report’s Key Features
• PDF with > 80 slides
• Excel file > 4,350 patents
• Overview of the most recent patents published in 2019 by MEMS players.
• Main patent applicants.
• Main MEMS technologies and devices analyzed:
– Inertial sensors (accelerometers, gyroscopes, IMUs)
– Microphones
– Microspeakers
– Ultrasonic sensors
– Gas sensors
– Pressure sensors
– Micromirrors
– MEMS Packaging
• IP dynamics and trends of the different MEMS devices.
• Comparison of recent IP and market activities.
• Noticeable 2019 patents from main players.
• Excel database containing all patents analyzed in the report, including technology and application segmentation.
Antenna for 5G patent landscape 2019 sampleKnowmade
Report’s Key Features
• PDF >120 slides
• Excel file >3,600 patents
• IP trends, including time-evolution of published patents, and countries of patent filings
• Ranking of main patent assignees
• Patent analysis for main applications (handsets, infrastructures & networks, vehicles) and technologies (MIMO, beamforming, antenna array, mm-wave, monopole antenna, dipole antenna, microstrip antenna, etc.)
• Key patents
• Key players’ IP position, and relative strength of their patent portfolios
• Key players’ IP profile: Samsung Electronics, Oppo Mobile, Huawei, and Intel
• Excel database containing all patents analyzed in this report, including technology and application segmentations
Cree (Wolfspeed) has the strongest patent portfolio in RF GaN technology, especially for GaN-on-SiC devices, well ahead of competitors like Sumitomo Electric and Fujitsu. The report provides an analysis of over 3,750 patents related to GaN devices for radio frequency applications, identifying the key patent holders and technology trends. It examines the intellectual property landscape for GaN semiconductors, integrated circuits, packaging, and key applications like power amplifiers, switches, and filters. The analysis shows American and Japanese companies dominating the RF GaN patent landscape, with growing activity from Chinese firms like HiWafer and new entrants focusing on areas like GaN-on-Silicon technology.
Report’s Key Features
• PDF with > 80 slides
• Excel file > 1,000 patents
• IP trends, including time-evolution of published patents, countries of patent filings, etc.
• Ranking of main patent assignees
• Key players’ IP position and relative strength of their patent portfolios
• Patent segmentation per application:
– CMOS image sensor (CIS)
– Memory
– MEMS
– LED
• Key patent identification and details
• IP profile of key players: Xperi, TSMC, YMTC
• Excel database containing all patents analyzed in the report, including technology and application segmentations
Report’s Key Features
• PDF with > 80 slides
• Excel file > 4,350 patents
• Overview of the most recent patents published in 2019 by MEMS players.
• Main patent applicants.
• Main MEMS technologies and devices analyzed:
– Inertial sensors (accelerometers, gyroscopes, IMUs)
– Microphones
– Microspeakers
– Ultrasonic sensors
– Gas sensors
– Pressure sensors
– Micromirrors
– MEMS Packaging
• IP dynamics and trends of the different MEMS devices.
• Comparison of recent IP and market activities.
• Noticeable 2019 patents from main players.
• Excel database containing all patents analyzed in the report, including technology and application segmentation.
Report’s Key Features
• PDF >160 slides
• Excel file >18,500 patents
• IP trends, including time-evolution of published patents, countries of patent filings, etc.
• Ranking of main patent assignees
• Main technologies IP analysis:
– Temperature-compensated acoustic wave filters
– Packaging (flip-chip, wafer-level packaging
– Functions and modules (duplexers, multiplexers)
• IP players’ key patents
• Key players’ IP position and relative strength of their patent portfolios
• IP profile of key players: Murata, TDK, Taiyo Yuden, Skyworks, Qualcomm, Broadcom, Qorvo, Samsung Electro Mechanics, Akoustis, Resonant, Infineon, CETC
• Excel database containing all patents analyzed in the report, including technology and application segmentations
Point-of-Need Testing: Application of Microfluidic Technologies - 2018 Report...Yole Developpement
Decentralized testing is now widespread, thanks to the endless possibilities enabled by microfluidic technologies.
More information on that report at https://www.i-micronews.com/report/product/point-of-need-testing-application-of-microfluidic-technologies.html
Which companies own patents in microLED display? What are their major thrust areas and
portfolio strength?
Yole Développement has identified close to 1,500
patents filed by 125 companies and organizations
relevant to the microLED display field. Among
these are multiple startups, display makers, OEMs,
semiconductor companies, LED makers, and
research institutions.
More information on that report at http://www.i-micronews.com/reports.html
Status of the Advanced Packaging Industry 2018 Report by Yole Developpement Yole Developpement
In the era of a slowing Moore’s Law, advanced packaging has emerged as the savior of future semiconductor development.
More information on that report at https://www.i-micronews.com/report/product/status-of-the-advanced-packaging-industry-2018.html
Status of Panel Level Packaging 2018 Report by Yole Developpement Yole Developpement
Panel level packaging players are ready for high volume production.
More information on that report at https://www.i-micronews.com/report/product/status-of-panel-level-packaging-2018.html
Next Generation Sequencing & DNA Synthesis: Technology, Consumables Manufactu...Yole Developpement
This document provides a summary of a report by Yole Développement on next-generation DNA sequencing and DNA synthesis technologies. The report provides an overview of the market and technology landscapes, including descriptions of established and emerging sequencing technologies. It also analyzes the supply chain and provides market data, forecasts, and analysis. The report finds that the number of sequencing instruments is expected to more than double by 2024, driving growth in the number of sequencing consumables from 1.28 million units in 2018 to 4.19 million units in 2024. This rapid adoption represents significant opportunities for companies along the semiconductor supply chain to provide enabling technologies for sequencing consumables.
How will AI impact the semiconductor market through consumer applications?
More information on that report at : https://www.i-micronews.com/report/product/hardware-and-software-for-ai-2018-consumer-focus.html
Microphones, Microspeakers and Audio Solutions Market and Technology Trends 2019Yole Developpement
The voice-based world is shaking up the audio industry, making it worth $20.8B in 2024.
More information on https://www.i-micronews.com/products/microphones-microspeakers-and-audio-solutions-market-and-technology-trends-2019/
Emerging semiconductor substrates are expected to grow at a 24% CAGR from 2018 – 2024.
More information on https://www.i-micronews.com/products/emerging-semiconductor-substrates-market-technology-trends-2019/
ttopstart - Business development and strategic planningttopstart B.V.
ttopstart operates at the intersection of science and business. Because life sciences and medical markets are highly challenging, it takes more than a breakthrough technology to reach the finish line. Whether it is exploring markets, strategic decision making or business development, ttopstart is your partner to take the next step. We provide concrete guidance, spur venture funding and expedite commercial success.
ttopstart's vision on modern medicine Introducing innovations in the healthcare sector is particularly challenging due to the many stakeholders involved, fierce regulations, long time to market and enormous upfront investments. For this reason, the pharmaceutical, biotechnology and medical technology industry are characterised by an extremely high attrition rate. You have to implement more than a sound business strategy to succeed. Our vision is that in all phases of business development, it is crucial to gain detailed insight into market opportunities, competition, the regulatory environment and stakeholder interests. This allows the creation of tailored commercialisation strategies that leverage the value of your developments and straighten the route to market. Second, we believe it is vital to effectively balance dilutive and non-dilutive funding and make use of only those resources that enforce your business. Finally, efforts should be targeted at deal making.
The ultimate goal of ttopstart is to enable a business to reach its full economic, scientific and societal potential - supporting the market introduction of breakthrough medical products.
Leadership in science and business consulting
ttopstart is a European science and business consulting company that supports innovative companies and research organisations with the commercialisation of breakthrough innovations.
The ttopstart team collaborates with more than 150 academic and corporate clients across Europe in the fields of life sciences, health and medical technology. We add value to the development of innovative products such as blood-based biomarker diagnostics, targeted immunotherapies and medical devices. We do this through the design of tailored business models, funding plans and commercialisation strategies - all based on the latest scientific and sector information.
Our services are always tailored to your specific needs and venture maturity, and include the following activities:
- Market research providing strategic market insights and intelligence;
- Strategic planning of the optimal route-to-market;
- In-house support;
- Financing consultancy providing access to dilutive and
non-dilutive funding.
Global Top 400 Immuno-Oncology Startups – Key Technologies, Pipeline, Deals a...OmicsX
Report for the first time identifies and profiles Top 400 Active Immuno-Oncology Startup companies from 24 different countries worldwide, developing 581 cancer targeting drugs; established between 2010 – 2019.
To bring this massive report on table, Industry experts for the first time analyzed nearly 650 I/O Startups established during this period and filter out, key 400 active drug developers, based on their technology, management capabilities and current funding status to further scaleup their drug discovery processes.
This highly precise 334 pages report is designed to keep information intact, informative and self-explanatory. Thus, Immuno-Oncology Startups 2020, will help organizations working on cancer research, to supercharge with lots of new decision-making information and jumpstart current partnering/marketing efforts.
Cancer diagnostics startup identification 2020 sampleKnowmade
Report’s Key Features
• PDF with > 430+ slides
• Identification & mapping of the startups that recently started to work in the field of cancer diagostics.
• Identification & mapping of the startups that recently started to work in the field of cancer diagnostics.
• Segmentation by technology (Medical imaging, Software, AI-based tool, Biochemical analysis, Molecular diagnostics, Lab-on-chip, Liquid biopsy etc.)
• Description of the startups and their current stage of product development, funding rounds and subsidies.
• Presentation of all their relevant published patent families.
• Description of key people and their background.
Antenna for 5G patent landscape 2019 flyerKnowmade
Report’s Key Features
• PDF >120 slides
• Excel file >3,600 patents
• IP trends, including time-evolution of published patents, and countries of patent filings
• Ranking of main patent assignees
• Patent analysis for main applications (handsets, infrastructures & networks, vehicles) and technologies (MIMO, beamforming, antenna array, mm-wave, monopole antenna, dipole antenna, microstrip antenna, etc.)
• Key patents
• Key players’ IP position, and relative strength of their patent portfolios
• Key players’ IP profile: Samsung Electronics, Oppo Mobile, Huawei, and Intel
• Excel database containing all patents analyzed in this report, including technology and application segmentations
Report’s Key Features
• PDF with > 310+ slides
• Identification of the startups that recently started to work in the field of Microfluidics
• Mapping of the new startups
• Segmentation by technology and application
• Focused analysis of the projects aiming at Oncology, Diabetes and Neurology.
• Description of the startups and their microfluidic-related projects
• Presentation of all their published patent families.
• Description of key people and their background.
• Excel database containing all patents analyzed in the report
Report’s Key Features
• PDF with > 200 slides
• Excel file > 2,500 patents
• IP trends, including time-evolution of published patents, countries of patent filings, etc.
• Patent segmentation per application: Optoelectronics and Photonics, Power, RF, PV and Sensors
• Ranking of main patent assignees
• Key players’ IP position and relative strength of their patent portfolios
• Established players and new entrants
• IP profile of key players, their key patents and their recent IP activity
• Patents recently expired and patents near expiration date
• Excel database containing all patents analyzed in the report, including technology and application segmentations
Solid electrolytes for lithium ion solid state batteries patent landscape 201...Knowmade
Report’s Key Features
• PDF with > 250 slides
• Excel file > 5,800 patents
• IP trends, including time-evolution of published patents, legal status, countries of patent filings, etc.
• Ranking of main patent assignees
• Patent categorization by type of electrolyte (polymer, inorganic, inorganic/polymer) and inorganic electrolyte materials (sulfide glass ceramics, Thio-LISICON, argyrodite, oxide glass ceramics, NASICON, perovskite, garnet, anti-perovskite, hydride)
• For each technical segment: IP dynamics, ranking of main patent assignees, newcomers, key IP players (leadership, blocking potential, portfolio strength), key patents, and recent development trends
• For each key IP player (100+ companies): Time-evolution of patenting activity, legal status of patents and countries of patent filings, patent segmentation by electrolyte material, IP strengths and weaknesses by electrolyte material
• Excel database containing all patents analyzed in this report, including technology and material segmentations
Report’s Key Features
• PDF with > 80 slides
• Excel file > 4,350 patents
• Overview of the most recent patents published in 2019 by MEMS players.
• Main patent applicants.
• Main MEMS technologies and devices analyzed:
– Inertial sensors (accelerometers, gyroscopes, IMUs)
– Microphones
– Microspeakers
– Ultrasonic sensors
– Gas sensors
– Pressure sensors
– Micromirrors
– MEMS Packaging
• IP dynamics and trends of the different MEMS devices.
• Comparison of recent IP and market activities.
• Noticeable 2019 patents from main players.
• Excel database containing all patents analyzed in the report, including technology and application segmentation.
Antenna for 5G patent landscape 2019 sampleKnowmade
Report’s Key Features
• PDF >120 slides
• Excel file >3,600 patents
• IP trends, including time-evolution of published patents, and countries of patent filings
• Ranking of main patent assignees
• Patent analysis for main applications (handsets, infrastructures & networks, vehicles) and technologies (MIMO, beamforming, antenna array, mm-wave, monopole antenna, dipole antenna, microstrip antenna, etc.)
• Key patents
• Key players’ IP position, and relative strength of their patent portfolios
• Key players’ IP profile: Samsung Electronics, Oppo Mobile, Huawei, and Intel
• Excel database containing all patents analyzed in this report, including technology and application segmentations
Cree (Wolfspeed) has the strongest patent portfolio in RF GaN technology, especially for GaN-on-SiC devices, well ahead of competitors like Sumitomo Electric and Fujitsu. The report provides an analysis of over 3,750 patents related to GaN devices for radio frequency applications, identifying the key patent holders and technology trends. It examines the intellectual property landscape for GaN semiconductors, integrated circuits, packaging, and key applications like power amplifiers, switches, and filters. The analysis shows American and Japanese companies dominating the RF GaN patent landscape, with growing activity from Chinese firms like HiWafer and new entrants focusing on areas like GaN-on-Silicon technology.
Report’s Key Features
• PDF with > 80 slides
• Excel file > 1,000 patents
• IP trends, including time-evolution of published patents, countries of patent filings, etc.
• Ranking of main patent assignees
• Key players’ IP position and relative strength of their patent portfolios
• Patent segmentation per application:
– CMOS image sensor (CIS)
– Memory
– MEMS
– LED
• Key patent identification and details
• IP profile of key players: Xperi, TSMC, YMTC
• Excel database containing all patents analyzed in the report, including technology and application segmentations
Report’s Key Features
• PDF with > 80 slides
• Excel file > 4,350 patents
• Overview of the most recent patents published in 2019 by MEMS players.
• Main patent applicants.
• Main MEMS technologies and devices analyzed:
– Inertial sensors (accelerometers, gyroscopes, IMUs)
– Microphones
– Microspeakers
– Ultrasonic sensors
– Gas sensors
– Pressure sensors
– Micromirrors
– MEMS Packaging
• IP dynamics and trends of the different MEMS devices.
• Comparison of recent IP and market activities.
• Noticeable 2019 patents from main players.
• Excel database containing all patents analyzed in the report, including technology and application segmentation.
Report’s Key Features
• PDF >160 slides
• Excel file >18,500 patents
• IP trends, including time-evolution of published patents, countries of patent filings, etc.
• Ranking of main patent assignees
• Main technologies IP analysis:
– Temperature-compensated acoustic wave filters
– Packaging (flip-chip, wafer-level packaging
– Functions and modules (duplexers, multiplexers)
• IP players’ key patents
• Key players’ IP position and relative strength of their patent portfolios
• IP profile of key players: Murata, TDK, Taiyo Yuden, Skyworks, Qualcomm, Broadcom, Qorvo, Samsung Electro Mechanics, Akoustis, Resonant, Infineon, CETC
• Excel database containing all patents analyzed in the report, including technology and application segmentations
Point-of-Need Testing: Application of Microfluidic Technologies - 2018 Report...Yole Developpement
Decentralized testing is now widespread, thanks to the endless possibilities enabled by microfluidic technologies.
More information on that report at https://www.i-micronews.com/report/product/point-of-need-testing-application-of-microfluidic-technologies.html
Which companies own patents in microLED display? What are their major thrust areas and
portfolio strength?
Yole Développement has identified close to 1,500
patents filed by 125 companies and organizations
relevant to the microLED display field. Among
these are multiple startups, display makers, OEMs,
semiconductor companies, LED makers, and
research institutions.
More information on that report at http://www.i-micronews.com/reports.html
Status of the Advanced Packaging Industry 2018 Report by Yole Developpement Yole Developpement
In the era of a slowing Moore’s Law, advanced packaging has emerged as the savior of future semiconductor development.
More information on that report at https://www.i-micronews.com/report/product/status-of-the-advanced-packaging-industry-2018.html
Status of Panel Level Packaging 2018 Report by Yole Developpement Yole Developpement
Panel level packaging players are ready for high volume production.
More information on that report at https://www.i-micronews.com/report/product/status-of-panel-level-packaging-2018.html
Next Generation Sequencing & DNA Synthesis: Technology, Consumables Manufactu...Yole Developpement
This document provides a summary of a report by Yole Développement on next-generation DNA sequencing and DNA synthesis technologies. The report provides an overview of the market and technology landscapes, including descriptions of established and emerging sequencing technologies. It also analyzes the supply chain and provides market data, forecasts, and analysis. The report finds that the number of sequencing instruments is expected to more than double by 2024, driving growth in the number of sequencing consumables from 1.28 million units in 2018 to 4.19 million units in 2024. This rapid adoption represents significant opportunities for companies along the semiconductor supply chain to provide enabling technologies for sequencing consumables.
How will AI impact the semiconductor market through consumer applications?
More information on that report at : https://www.i-micronews.com/report/product/hardware-and-software-for-ai-2018-consumer-focus.html
Microphones, Microspeakers and Audio Solutions Market and Technology Trends 2019Yole Developpement
The voice-based world is shaking up the audio industry, making it worth $20.8B in 2024.
More information on https://www.i-micronews.com/products/microphones-microspeakers-and-audio-solutions-market-and-technology-trends-2019/
Emerging semiconductor substrates are expected to grow at a 24% CAGR from 2018 – 2024.
More information on https://www.i-micronews.com/products/emerging-semiconductor-substrates-market-technology-trends-2019/
ttopstart - Business development and strategic planningttopstart B.V.
ttopstart operates at the intersection of science and business. Because life sciences and medical markets are highly challenging, it takes more than a breakthrough technology to reach the finish line. Whether it is exploring markets, strategic decision making or business development, ttopstart is your partner to take the next step. We provide concrete guidance, spur venture funding and expedite commercial success.
ttopstart's vision on modern medicine Introducing innovations in the healthcare sector is particularly challenging due to the many stakeholders involved, fierce regulations, long time to market and enormous upfront investments. For this reason, the pharmaceutical, biotechnology and medical technology industry are characterised by an extremely high attrition rate. You have to implement more than a sound business strategy to succeed. Our vision is that in all phases of business development, it is crucial to gain detailed insight into market opportunities, competition, the regulatory environment and stakeholder interests. This allows the creation of tailored commercialisation strategies that leverage the value of your developments and straighten the route to market. Second, we believe it is vital to effectively balance dilutive and non-dilutive funding and make use of only those resources that enforce your business. Finally, efforts should be targeted at deal making.
The ultimate goal of ttopstart is to enable a business to reach its full economic, scientific and societal potential - supporting the market introduction of breakthrough medical products.
Leadership in science and business consulting
ttopstart is a European science and business consulting company that supports innovative companies and research organisations with the commercialisation of breakthrough innovations.
The ttopstart team collaborates with more than 150 academic and corporate clients across Europe in the fields of life sciences, health and medical technology. We add value to the development of innovative products such as blood-based biomarker diagnostics, targeted immunotherapies and medical devices. We do this through the design of tailored business models, funding plans and commercialisation strategies - all based on the latest scientific and sector information.
Our services are always tailored to your specific needs and venture maturity, and include the following activities:
- Market research providing strategic market insights and intelligence;
- Strategic planning of the optimal route-to-market;
- In-house support;
- Financing consultancy providing access to dilutive and
non-dilutive funding.
Global Top 400 Immuno-Oncology Startups – Key Technologies, Pipeline, Deals a...OmicsX
Report for the first time identifies and profiles Top 400 Active Immuno-Oncology Startup companies from 24 different countries worldwide, developing 581 cancer targeting drugs; established between 2010 – 2019.
To bring this massive report on table, Industry experts for the first time analyzed nearly 650 I/O Startups established during this period and filter out, key 400 active drug developers, based on their technology, management capabilities and current funding status to further scaleup their drug discovery processes.
This highly precise 334 pages report is designed to keep information intact, informative and self-explanatory. Thus, Immuno-Oncology Startups 2020, will help organizations working on cancer research, to supercharge with lots of new decision-making information and jumpstart current partnering/marketing efforts.
Presentation To Seda Technology ProgrammeElton050505
The document discusses several topics related to global commercialization of ICT products and services:
1) Globalization has led to an interconnected global marketplace without barriers to technology and business spread worldwide.
2) ICT products and services now commercialized globally include point-of-sale systems, e-commerce platforms, internet and telecommunications infrastructure.
3) There is a shortage of over 37,000 ICT workers in South Africa across many roles like managers, analysts, programmers and technicians needed to support growing commercialization of ICT.
Healthcare software and SaaS companies continue to be in high demand as regulatory, technological and social influences drive significant change. From electronic health records to point-of-care solutions and now to m-health solutions, companies in this sector continue to receive significant interest from buyers. This Market Spotlight webcast, designed for owners, executives and investors in healthcare technology, will address attributes driving interest and valuations with perspectives from analysts, bankers, investors, and CEOs who have recently sold.
New Frontier Data's mission is to elevate the discussion around the legal cannabis industry globally by providing unbiased vetted information and educating stakeholders to make informed decisions.
This presentation discusses the impact of artificial intelligence on technology entrepreneurship. It begins with an introduction to AI and its ability to process and analyze vast amounts of data. The presentation then covers topics like AI applications in different industries, the role of AI in product development and innovation, and the impact on jobs. It also discusses challenges for AI startups like data collection and model interpretability, as well as opportunities in industries like healthcare and finance. The conclusion emphasizes how AI is transforming businesses by automating tasks and providing insights, while also creating new opportunities for entrepreneurs.
Axtria offers sales analytics and marketing analytics services with an optimal mix of people, process and technology to deliver insights for commercial operations.
This document proposes a business-oriented social network called WeSpline that connects enterprises, startups, investors and other players in the technology ecosystem. It aims to address the fragmented and inefficient process of enterprises searching for innovative technologies and startups finding clients. The network will use intelligent algorithms to help users search, connect, communicate and do business across borders more easily. It will generate revenue from premium subscriptions and advertising. The founders are seeking $300,000 to build an MVP and launch to initial users, or $1 million to launch more broadly.
The document proposes a business-oriented social network called WeSpline that connects enterprises, startups, and other players in the technology ecosystem. It aims to address the fragmented and inefficient process of enterprises discovering innovative technologies and startups finding clients. The network will use intelligent algorithms to help users search, learn about, and communicate with each other across the globe, saving them time and money. It will launch initially in the US, Israel, and Brazil targeting industries like cybersecurity and logistics tech. Revenue will come from premium subscriptions and advertising on the network.
This document proposes a business-oriented social network that connects enterprises, startups, and other players in the technology ecosystem. It aims to address the fragmented and inefficient process of enterprises discovering innovative technologies and startups finding clients. The network will use intelligent algorithms to help users search, learn about, and connect with each other across the globe. This will save time and money for all users while expanding their horizons. The founders plan to launch a minimum viable product and target "core" industries and countries initially. Financial projections estimate the network could generate over $900 million in annual revenue by 2027.
This document proposes a business-oriented social network called WeSpline that connects players in the high-tech ecosystem globally. It aims to address the fragmented and inefficient process of enterprises finding technological solutions and startups finding clients. WeSpline will use intelligent algorithms to help enterprises discover technologies and opportunities, and help startups get exposed to enterprises and investors worldwide. It will have free basic services and premium subscription services for advanced features. The founders plan to release it initially in the US, Israel, and Brazil targeting certain industries, and distribute it through industry hubs to gain early traction and scale.
The state of the whole AI & ML sector in Europe and North America – research ...Mindtrek
AI IN FUTURE TECH - Thursday 30th
MIKAEL JUNTUNEN, CEO, CATAPULT
Smart City Mindtrek 2020 - conference
28th- 30th – January
Tampere, Finland
www.mindtrek.org/2020/
Photoacoustic imaging technologies in the biomedical domain are in full growth from an IP point of view, and have began to move in the clinical field. If Japanese companies Canon and Fujifilm are the main IP holder, the market is held by US actors : ENDRA Life Sciences, VisualSonics, Seno Medical Instruments, OptoSonics or TomoWave Laboratories.
This patent landscape focuses on photoacoustic imaging in biomedicine. Photoacoustic imaging is a safe, non-invasive, non-ionizing imaging technique. The technique offers several advantages and represents a great alternative to traditional medical imaging approaches. The innovation of photoacoustic imaging for biomedical purposes is mainly driven by the need to enhance the efficiency of the detection and diagnostic of cancer.
KEY FEATURES OF THE REPORT
The report provides essential patent data for biomedical photoacoustic imaging including:
Time evolution of patent publications and countries of patent filings.
Current legal status of patents.
Ranking of main patent applicants.
Joint developments and IP collaboration network of main patent applicants.
Key patents.
Granted patents near expiration.
Relative strength of main companies IP portfolio.
Photoacoustic imaging IP profiles of 15 major companies with key patents, partnerships, and IP strength and strategy.
The report also provides an extensive Excel database with all patents analyzed in the study.
NanoDiagX is a company that develops novel bio-nanotechnology platforms using gold nanoparticles for rapid, direct, and sensitive detection of infectious diseases like hepatitis C, tuberculosis, and cancer biomarkers. Its flagship HCV Nanogold Assay can detect hepatitis C virus with 92% sensitivity and 89% specificity. The report provides an overview of NanoDiagX's product pipeline including its nanoparticle-based tests in development for tuberculosis and cancer that aim to offer inexpensive and reliable diagnostics for these diseases. It is headquartered in New Cairo, Egypt.
This document outlines the typical sections included in a business plan, including an introductory section, executive summary, industry analysis, description of the venture, production/operations plan, marketing plan, organizational plan, risk assessment, and financial plan. It emphasizes that the key factors critical to every new venture that should be highlighted are the people involved, the opportunity, pricing considerations, competition, the broader context/environment, and an assessment of potential risks and rewards. A successful plan depends greatly on effective execution by knowledgeable, well-connected people pursuing a large market opportunity.
The document proposes a business-oriented social network called WeSpline that connects enterprises, startups, and other players in the technology ecosystem. It aims to address the fragmented and inefficient process of enterprises discovering innovative technologies and startups finding clients. The network will use intelligent algorithms to help users search, learn about, and communicate with each other across the globe, saving them time and money. It will launch initially in the US, Israel, and Brazil targeting industries like cybersecurity and logistics tech. Revenue will come from premium subscriptions and ads on the network.
Signicent LLP (IND & USA) is a well-established firm with 80+ experts that assist businesses globally in their technology innovation, patents, trademarks, valuation, licensing, tech-transfer & market research needs.
This document describes the Medical Device Gateway (MDG) program, a Chinese-Finnish network aimed at commercializing medical device technologies. The program seeks to bring Chinese medical device innovations to European markets through Finnish companies, and to open Chinese markets to Finnish medical ventures. It identifies opportunities in the large and growing Chinese IVD market and regulatory changes making it more accessible. The document outlines the program's operations of establishing strategic partnerships between Finnish and Chinese organizations to more quickly develop and place new products on global markets.
Similar to Cancer diagnostics startup identification 2020 flyer (20)
The report analyzes the patent landscape related to antenna integrated in package (AiP). Over 140 entities have filed AiP patents, with the main assignees being SJ Semiconductor, TSMC, Samsung Electro-Mechanics, Huawei, MediaTek, IBM, ASE, SPIL, NCAP, Qualcomm, and Murata. The report provides a detailed analysis of these players' patent portfolios, technologies, strategies, and key patents. It also includes an Excel database of over 1,500 analyzed AiP patents. The report finds the IP landscape is dominated by foundries/OSATs and major companies, with newcomers being Chinese firms focusing on wafer-level packaging for integrated antennas. The IP
Next generation power modules - patent landscape 2021 - sampleKnowmade
The advent of EV/HEV technology has acted as a catalyst for innovation, leading to an acceleration in applications for power module related patents since 2010. Who are the main IP players? How do they address the new challenges? Who are the new players and IP challengers taking the big opportunities arising from the emerging EV/HEV market?
Next generation power modules - patent landscape 2021- flyerKnowmade
The advent of EV/HEV technology has acted as a catalyst for innovation, leading to an acceleration in applications for power module related patents since 2010. Who are the main IP players? How do they address the new challenges? Who are the new players and IP challengers taking the big opportunities arising from the emerging EV/HEV market?
Report’s Key Features
• PDF with > 230 slides
• Excel file > 3,000 patent families
• Main IP dynamics and key trends.
• IP leaders, most active players and newcomers.
• IP portfolio strength of key players, and their technology/application focus.
• Time evolution of patents filings by company, countries, and technology.
• IP collaborations and IP transfers between key organizations.
• Insights into the status of RF GaN patented technologies, identifying trends for each technology and application.
• Extensive Excel database of over 3,000 patent families with all patent information and technology segmentation.
Report’s Key Features
• PDF with > 270 slides
• Excel file > 9,500 patents
• IP trends, including time-evolution of published patents, countries of patent filings, etc.
• Ranking of main patent assignees
• Key players’ IP position and relative strength of their patent portfolios
• Patent segmentation:
– Vertical power device (vertical transistor, vertical diode),
– Normally-off (E-mode transistor, cascode topology),
– Integration (monolithic E/D-mode, SiP/SoC, power IC),
– GaN-on-Si,
– GaN-on-Sapphire,
– Selective area p-type doping (ion implantation, p-GaN regrowth),
– Current collapse,
– Thermal management,
– Stray inductance,
– EV/HEV,
– fast charging,
– wireless charging.
• Key patent identification and details
• IP profile of 40 key players: Infineon, Panasonic, Toshiba etc.
• Excel database containing all patents analyzed in the report, including technology and application segmentations
Report’s Key Features
• PDF >130 slides
• Excel file with >3,800 patents
• Competitive landscape from a patent perspective, offering a very complementary vision to market research.
• Key patent owners, their IP and technology strategies and their future intents.
• New entrants, their technology and their market areas of interest.
• Know competitors’ strengths and weaknesses in terms of patents and technologies.
• Follow technology developments, identify emerging technologies and know key technical solutions to solve hot technical issues.
• Identify free technologies which can be used safely and to mitigate the risks of patent infringement.
• Identify technologies to acquire and potential R&D partners.
• Benefit from a useful Excel database with all patents analyzed in the report, including technology segmentation.
I phone X proximity sensor and food illuminator patent to product mapping sa...Knowmade
Report’s Key Features
• PDF > 110 slides
• Link between key product features and patents owned by STMicroelectronics, Lumentum, and Philips
• Essential patent portfolio analysis for STMicroelectronics, Lumentum, and Philips, related to VCSEL and ToF sensors. Includes:
– Time evolution of patent publications, and countries of patent filings
– Current legal status of patents
– Citation network and competitive IP networks
• Deep insight into technology data, including teardown analysis of:
– STMicroelectronics ToF sensor
– Philips’ VCSEL source
– Lumentum’s VCSEL array
3D NAND Flash Memory devices appeared on the market in 2015 with 3D V-NAND – 32L of Samsung Electronics, followed in 2016 with 3D NAND V2 – 36L of SK Hynix, 3D NAND – 48L of Toshiba/SanDisk and 3D NAND – 32L of Micron/Intel. In recent times, it happens a lot in the 3D non-volatile memory (3D NVM) field with the acquisition of SanDisk by Western Digital, The investments of Chinese government in memory, or the Intel announcement of the Intel/Micron separation for further development of 3D NAND. We witnessed these evolves in the IP landscape through the recent increase of 3D NVM-related patents filed by Chinese players (YMTC/YRST) and the numerous Samsung’s patents published the latest months in China, USA and Korea, reflecting its willing to strengthen its 3D NVM IP portfolio. Also, we observed non-practicing entities (NPEs) like Conversant IP and WiLAN are entering the landscape. The presence of such companies is a tangible sign of the market explodes, heralding future IP battles when they will assert their patents to make money.
In this report, KnowMade has thoroughly investigated the patents related to 3D non-volatile memories and draws a picture of the current patent landscape and its potential evolution. SanDisk/Western Digital, Samsung and Toshiba are leading the 3D NVM patent landscape. They hold together more than 65% of the patents, Western Digital and Toshiba signed a JV extension until 2029, and Samsung and Western Digital renewed a patent cross-license agreement until 2024. On the other hand, we witness the emergence of Chinese players in the IP landscape. Patent activity related to 3D non-volatile memory (3D NVM) emerged in the 1990s with Toshiba and SanDisk. They signed Joint Venture agreement on Flash Memory in 1999. In the end 2000s, the research and development of 3D architectures appeared with IP related to BiCS (Bit Cost Scalable, SanDisk and Toshiba), TCAT (Terabit Cell Array Transistor, Samsung Electronics) and FG (Floating Gate, SK Hynix). Few years later Micron Technology developed also FG architecture, and Macronix International developed in 2015 SGVC architecture (Single Gate Vertical Channel). Since 2008, the number of patents related to 3D NVM has continuously increased, and today the 3D NVM patent landscape represents over 3,400 patent families including more than 9,400 patents. The landscape is very competitive, with several big companies and the entrance of Chinese players these last years.
Pumps for microfluidic devices patent landscape 2017 SAMPLEKnowmade
The worldwide market for pumps for microfluidic devices is growing quickly. Pumps are the cornerstone of microfluidic systems. They are the key component that allows the motion of fluids in an accurate and reliable manner through a device’s reservoirs, chambers and microchannels. According to Market Research Future, the global micropump market should reach $5.28 billion by 2027, with a compound annual growth rate (CAGR) of 17.2%. The biomedical and pharmaceutical industries are driving the market. Micropumps are essential in DNA chips, lab-on-a-chip and drug delivery. They are also used in other domains, including flow chemistry, inkjet printing or electronic cooling. The intellectual property (IP) landscape related to pumps for microfluidic devices involves both industrial applicants like Epson, Baxter, Debiotech, Honeywell and Medtronic, and academic ones like Caltech, Stanford and Fraunhofer. This indicates that technologies for micropumps are still in development. This development is driven in particular by an increasing number of biomedical devices but also by the increasing need for micropumping systems for microelectronic components. To match all the various applications, many different technologies have been developed. Mechanical pumps include electrostatic, electromagnetic, piezoelectric, thermopneumatic, shape memory alloy, bimetallic and ion polymer conducting film technology. Non-mechanical pumps include magneto-hydrodynamic, electro-hydrodynamic, electroosmotic, electrowetting, electrochemical and bubble-type. This patent landscape report analyzes IP activity for each technology. The analysis of the technical issues addressed by patents related to pumps for microfluidic devices supports what we observe in the market. Mechanical pumps dominate, but new applicants, in particular from China, could accelerate the development of non-mechanical pumps for microfluidics.
The report provides essential patent data for FLUIDIGM’s portfolio including:
• Time evolution of patent publications and countries of patent filings
• Current legal status of patents
• Citation network, IP collaboration and competitive networks
• Inventor identification
• Key patent analysis
• Patents recently expired
• Granted patents near expiration
The report also provides an extensive Excel database with all patents analyzed in the study.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Cancer diagnostics startup identification 2020 flyer
1. Startup Identification Report
Cancer Diagnostics
Startup Identification – August 2020
What are the startups that have emerged in the cancer diagnostics market?
What are they working on? Who are the key people in these companies?
REPORT OUTLINE
• Cancer diagnostics
• Startup Identification Report
• August 2020
• Ref.: KM20007
• PDF: 430+ slides
• € 1,990 for a multi-user license
REPORT’S KEY FEATURES:
• Identification & mapping of the
startups that recently started to
work in the field of cancer
diagnostics.
• Segmentation by technology
(Medical imaging, Software, AI-
based tool, Biochemical analysis,
Molecular diagnostics, Lab-on-chip,
Liquid biopsy etc.)
• Description of the startups and their
current stage of product
development, funding rounds and
subsidies.
• Presentation of all their relevant
published patent families.
• Description of key people and their
background.
This report will help you:
➢Identify new business opportunities.
➢Identify new competitors-to-be.
➢Understand the evolution of key
trends in IP and technology
development.
RELATED REPORTS
• Immunotherapy in Oncology –
Startup Identification
• Microfluidics – Startup Identification
• CTC: isolation & detection – Patent
Landscape Analysis
• Artificial Intelligence in Medical
Diagnostics – Patent Landscape
• Other related reports
The World Health Organization estimates that cancer was responsible for the death of about
9.6 million people in 2018 making of it a leading cause of death worldwide. A delay in the
treatment of cancer can result in a considerable decrease of the patient’s chance of survival.
Therefore the cancer diagnostics market is booming and highly competitive with a large
number of big and small players operating in different market segments. Moreover, a strong
need for new diagnostics exists to allow earlier detection with higher sensitivity and higher
specificity. New startups are founded every year with the aim of developing the next big
diagnostic technology. In this highly diverse and rapidly changing ecosystem, it is crucial to
identify new players and monitor their activities to determine opportunities, threats,
potential partnerships and collaborations. Because of their small size and technological
diversity, these young companies are hard to identify by conventional approaches (web
searches, workshops etc.). In this report, Knowmade has thus investigated patents related to
cancer diagnostics in order to identify startups through their patent filings. 154 startups
having filed their first patent application between 2018-2020 were thus identified, and for
74 of them, the report describes their main activity, products, patents, and key people
among their staff. This study reveals that molecular diagnostic is the market that is the more
explored by the selected startups, with an emphasis on the applications related to genetic
testing. Medical imaging is also a field of interest for several startups identified. Most of
which are working on software solutions to improve the interpretation of medical images
using artificial intelligence.
Why use patents to identify startups?
Detecting hidden companies – Looking at patent documents makes it possible to identify
companies that do not communicate much or even at all. It is a good way to detect
companies that could not be found using more conventional methods (e.g. trade fairs,
conferences, web searches, etc.).
Assessing the technology – Technology is one of the keys to a startup’s success and being
able to understand and assess it is highly valuable. The specification of a patent document
includes a lot of technical information that can be used to determine the advantages
brought by new inventions. The patent claims can also be used to determine the protection
the applicant is asking for, and therefore where its interest resides.
Identifying the key people – The success of a startup is strongly linked to the team that
composes it. It is therefore important to know the founders and inventors to assess the odds
of its success. Patents enable the identification of inventors inside the companies. These
inventors are technical experts who have laid the foundation of the technology the startup is
developing. Describing the background of key people can help in understanding the startup
project, and their history can reveal the extent of the know-how they have accumulated.
Over 150 startups working in the field of cancer diagnostics were identified
Startup identification Technology assessment Company's key people
2. Patent Description
This report includes a detailed description of all the patents filed by identified startups. The elements provided in each
overview slide provide essential information to quickly understand the patented technology. For each patent family
described, the publication number of Granted/Registered and Pending members are provided, as well as the abstract, the
first claim, relevant information about the invention and the most relevant figure (e.g. figure explaining how the invention
can be carried out, illustrating its efficacy, etc.).
Startup Identification
Startups have been identified by screening the patent documents published in 2019/2020 claiming technologies related to
cancer diagnostics. For each startup identified, the report provides a complete description of its activity and the stage of
development of its product. Information about funding rounds and subsidies are also described.
Cancer diagnostics – Startup Identification – August 2020
3. ABOUT KNOWMADE
Specializing in patent analysis and scientific information, Knowmade provides technology intelligence and IP strategy
consulting services. The company supports R&D organizations, industrial companies, and investors in their business
development by offering them a deep understanding of their IP environment and technology trends. Knowmade’s experts
provide art search, patent landscape analysis, scientific literature analysis, patent valuation, IP due diligence, and freedom-
to-operate analysis. In parallel, the company proposes litigation/licensing support, technology scouting, and IP/technology
watch service. Knowmade’s analysts combine their technical and patent expertise with powerful analytics tools and
proprietary methodologies to deliver relevant patent analyses and scientific reviews.
Brice SAGOT, PhD
CTO and co-founder of Knowmade,
Brice leads the Biotechnology and Life
Sciences department. He holds a PhD in
Molecular Biology from the University of
Nice Sophia-Antipolis (France).
Contact: brice.sagot@knowmade.fr
AUTHORS
Key People Description
This report includes a description of the key people and/or inventors involved in each selected startup. Knowing the key
people behind a startup helps assessing its chances of success by determining their individual strength and their
complementarity. This report is focused on the description of the people who have a technical background. For each key
person, the report shows a summary of their educational background, employment history, as well as their other current
activities and a link to their LinkedIn profiles.
Olivier Thomas, MSc
Olivier works at Knowmade in the field of
Biotechnology and Life Sciences. He holds an
MSc in Molecular and Cellular Biology from
Paris VI University (France). He also holds an
Industrial Property International Studies
Diploma (Patent, Trademark and Design
Law) from the CEIPI (Strasbourg, France).
Contact: olivier.thomas@knowmade.fr
TABLE OF CONTENTS
INTRODUCTION 5
- Objectives of the report
- Scope of the report
METHODOLOGY 8
- Patent search, selection and analysis
- Search strategy
- Terminologies for patent analysis
- Segmentation
EXECUTIVE SUMMARY 16
-Startups mapping
-Key facts
-Summary table of the identified and described companies
-Summary table of the identified companies with too little
information available
NEW STARTUPS 37
-Startup 1 to Startup 74
KNOWMADE PRESENTATION 437
Cancer diagnostics – Startup Identification – August 2020
4. PAYMENT METHODS
Order online: Click here
Check
To pay your invoice using a check, please mail your check to the
following address:
KnowMade S.A.R.L.
2405 route des Dolines, Le Drakkar D
06560 Valbonne Sophia Antipolis
FRANCE
Money Transfer
To pay your invoice using a bank money wire transfer, please
contact your bank to complete the process. Here is the information
you will need to submit the payment:
Payee: KnowMade S.A.R.L.
Bank: Banque Populaire Méditerranée, CAP 3000 Quartier du
lac, 06700 St Laurent du Var
IBAN: FR76 1460 7003 6360 6214 5695 139
BIC/SWIFT: CCBPFRPPMAR
Paypal
To pay your invoice via PayPal, you must first register at
www.paypal.com. You can then send money to KnowMade S.A.R.L.
by entering our email address (contact@knowmade.fr) as the
recipient and entering the invoice amount.
RETURN ORDER BY:
Email: contact@knowmade.fr
Mail: KnowMade S.A.R.L. 2405 route des Dolines, 06560 Valbonne
Sophia Antipolis, FRANCE
SHIP TO
Name (Mr/Ms/Dr/Pr):
______________________________________
Job Title:
______________________________________
Company:
______________________________________
Address:
______________________________________
City:
______________________________________
State:
______________________________________
Postcode/Zip:
______________________________________
Country:
______________________________________
VAT ID Number for EU members:
______________________________________
Tel:
______________________________________
Email:
______________________________________
Date:
______________________________________
ORDER FORM
Cancer Diagnostics
Startup Identification – August 2020
PRODUCT ORDER
€1,990 – Multi-user license*
For the price in dollars, please use the current day’s
exchange rate. French customers, please add 20% for
VAT.
Upon payment reception, all reports are delivered
electronically in pdf format
*The report can be shared with the employees of the Company
purchasing the report. Subsidiaries and joint-ventures are
excluded. Please be aware that the report is watermarked on
each page, with the name of the recipient and the organization
(the name mentioned on the PO).
I hereby accept Knowmade’s Terms and Conditions of Sale
Signature:
Ref.: KM20007
5. Definitions
“Acceptance”: Action by which the Buyer accepts the terms and conditions of sale in their entirety. It is done by signing the purchase order which
mentions “I hereby accept Knowmade’s Terms and Conditions of Sale”.
“Buyer”: Any business user (i.e. any person acting in the course of its business activities, for its business needs) entering into the following general
conditions to the exclusion of consumers acting in their personal interests.
“Contracting Parties” or “Parties”: The Seller on the one hand and the Buyer on the other hand.
“Intellectual Property Rights” (“IPR”) means any rights held by the Seller in its Products, including any patents, trademarks, registered models, designs,
copyrights, inventions, commercial secrets and know-how, technical information, company or trading names and any other intellectual property rights
or similar in any part of the world, notwithstanding the fact that they have been registered or not and including any pending registration of one of the
above mentioned rights.
“License”: For the reports and databases, 2 different licenses are proposed. The buyer has to choose one license:
1. Single-user license: a single individual at the company can use the report.
2. Multi-user license : The report can be shared with the employees of the company purchasing the report. Subsidiaries & joint-ventures are excluded.
“Products”: Reports are established in PowerPoint and delivered on a PDF format and the database may include Excel files.
“Seller”: Based in Sophia Antipolis (France headquarters), Knowmade is a technology intelligence company specialized in the research and analysis of
scientific and technical information. We provide patent landscapes and scientific state of the art with high added value to businesses and research
laboratories. Our intelligence digests play a key role to define your innovation and development strategy.
1. Scope
1.1 The Contracting Parties undertake to observe the following general conditions when agreed by the Buyer and the Seller. ANY ADDITIONAL,
DIFFERENT, OR CONFLICTING TERMS AND CONDITIONS IN ANY OTHER DOCUMENTS ISSUED BY THE BUYER AT ANY TIME ARE HEREBY OBJECTED TO BY
THE SELLER, SHALL BE WHOLLY INAPPLICABLE TO ANY SALE MADE HEREUNDER AND SHALL NOT BE BINDING IN ANY WAY ON THE SELLER.
1.2 This agreement becomes valid and enforceable between the Contracting Parties after clear and non-equivocal consent by any duly authorized
person representing the Buyer. For these purposes, the Buyer accepts these conditions of sales when signing the purchase order which mentions “I
hereby accept Knowmade’s Terms and Conditions of Sale”. This results in acceptance by the Buyer.
1.3 Orders are deemed to be accepted only upon written acceptance and confirmation by the Seller, within [7 days] from the date of order, to be sent
either by email or to the Buyer’s address. In the absence of any confirmation in writing, orders shall be deemed to have been accepted.
2. Mailing of Products
2.1 Products are sent by email to the Buyer:
- within [1] month from the order for Products already released; or
- within a reasonable time for Products ordered prior to their effective release. In this case, the Seller shall use its best endeavours to inform the Buyer
of an indicative release date and the evolution of the work in progress.
2.2 Some weeks prior to the release date the Seller can propose a pre-release discount to the Buyer.
The Seller shall by no means be responsible for any delay in respect of article 2.2 above, and including in cases where a new event or access to new
contradictory information would require for the analyst extra time to compute or compare the data in order to enable the Seller to deliver a high
quality Products.
2.3 The mailing of the Product will occur only upon payment by the Buyer, in accordance with the conditions contained in article 3.
2.4 The mailing is operated through electronic means either by email via the sales department. If the Product’s electronic delivery format is defective,
the Seller undertakes to replace it at no charge to the Buyer provided that it is informed of the defective formatting within 90 days from the date of
the original download or receipt of the Product.
2.5 The person receiving the Products on behalf of the Buyer shall immediately verify the quality of the Products and their conformity to the order.
Any claim for apparent defects or for non-conformity shall be sent in writing to the Seller within 8 days of receipt of the Products. For this purpose, the
Buyer agrees to produce sufficient evidence of such defects.
2.6 No return of Products shall be accepted without prior information to the Seller, even in case of delayed delivery. Any Product returned to the Seller
without providing prior information to the Seller as required under article 2.5 shall remain at the Buyer’s risk.
3. Price, invoicing, and payment
3.1 Prices are given in the orders corresponding to each Product sold on a unit basis or corresponding to annual subscriptions. They are expressed to
be inclusive of all taxes. The prices may be reevaluated from time to time. The effective price is deemed to be the one applicable at the time of the
order.
3.2 Payments due by the Buyer shall be sent by cheque payable to Knowmade, PayPal, or by electronic transfer to the following account:
Banque Populaire Méditerranée, CAP 3000 Quartier du lac, 06700 St Laurent du Var
BIC or SWIFT code: CCBPFRPPMAR
IBAN: : FR76 1460 7003 6360 6214 5695 139
To ensure payment, the Seller reserves the right to request down payments from the Buyer. In this case, the need of down payments will be
mentioned on the order.
3.3 Payment is due by the Buyer to the Seller within 30 days from invoice date, except in the case of a particular written agreement. If the Buyer fails
to pay within this time and fails to contact the Seller, the latter shall be entitled to invoice interest in arrears based on the annual rate Refi of the
«BCE» + 7 points, in accordance with article L. 441-6 of the French Commercial Code. Our publications (report, database, tool...) are delivered only
after reception of the payment.
3.4 In the event of termination of the contract, or of misconduct, during the contract, the Seller will have the right to invoice at the stage in progress,
and to take legal action for damages.
4. Liabilities
4.1 The Buyer or any other individual or legal person acting on its behalf, being a business user buying the Products for its business activities, shall be
solely responsible for choosing the Products and for the use and interpretations he makes of the documents it purchases, of the results he obtains, and
of the advice and acts it deduces thereof.
TERMS AND CONDITIONS OF SALES
6. 4.2 The Seller shall only be liable for (i) direct and (ii) foreseeable pecuniary loss, caused by the Products or arising from a material breach of this
agreement
4.3 In no event shall the Seller be liable for:
a) damages of any kind, including without limitation, incidental or consequential damages (including, but not limited to, damages for loss of profits,
business interruption and loss of programs or information) arising out of the use of or inability to use the Seller’s website or the Products, or any
information provided on the website, or in the Products;
b) any claim attributable to errors, omissions or other inaccuracies in the Product or interpretations thereof.
4.4 All the information contained in the Products has been obtained from sources believed to be reliable. The Seller does not warrant the accuracy,
completeness adequacy or reliability of such information, which cannot be guaranteed to be free from errors.
4.5 All the Products that the Seller sells may, upon prior notice to the Buyer from time to time be modified by or substituted with similar Products
meeting the needs of the Buyer. This modification shall not lead to the liability of the Seller, provided that the Seller ensures the substituted Product is
similar to the Product initially ordered.
4.6 In the case where, after inspection, it is acknowledged that the Products contain defects, the Seller undertakes to replace the defective products as
far as the supplies allow and without indemnities or compensation of any kind for labor costs, delays, loss caused or any other reason. The
replacement is guaranteed for a maximum of two months starting from the delivery date. Any replacement is excluded for any event as set out in
article 5 below.
4.7 The deadlines that the Seller is asked to state for the mailing of the Products are given for information only and are not guaranteed. If such
deadlines are not met, it shall not lead to any damages or cancellation of the orders, except for non-acceptable delays exceeding [4] months from the
stated deadline, without information from the Seller. In such case only, the Buyer shall be entitled to ask for a reimbursement of its first down
payment to the exclusion of any further damages.
4.8 The Seller does not make any warranties, express or implied, including, without limitation, those of saleability and fitness for a particular purpose,
with respect to the Products. Although the Seller shall take reasonable steps to screen Products for infection of viruses, worms, Trojan horses or other
codes containing contaminating or destructive properties before making the Products available, the Seller cannot guarantee that any Product will be
free from infection.
5. Force majeure
The Seller shall not be liable for any delay in performance directly or indirectly caused by or resulting from acts of nature, fire, flood, accident, riot,
war, government intervention, embargoes, strikes, labor difficulties, equipment failure, late deliveries by suppliers or other difficulties which are
beyond the control, and not the fault of the Seller.
6. Protection of the Seller’s intellectual property
6.1 All intellectual property rights attached to the Products are and remain the property of the Seller and are protected under French and international
copyright law and conventions.
6.2 The Buyer agreed not to disclose, copy, reproduce, redistribute, resell or publish the Product, or any part of it to any other party other than
employees of its company. The Buyer shall have the right to use the Products solely for its own internal information purposes. In particular, the Buyer
shall therefore not use the Product for purposes such as:
- Information storage and retrieval systems;
- Recordings and re-transmittals over any network (including any local area network);
- use in any timesharing, service bureau, bulletin board or similar arrangement or public display;
- Posting any Product to any other online service (including bulletin boards or the Internet);
- Licensing, leasing, selling, offering for sale or assigning the Product.
6.3 The Buyer shall be solely responsible towards the Seller of all infringements of this obligation, whether this infringement comes from its employees
or any person to whom the Buyer has sent the Products and shall personally take care of any related proceedings, and the Buyer shall bear related
financial consequences in their entirety.
6.4 The Buyer shall define within its company point of contact for the needs of the contract. This person will be the recipient of each new report in PDF
format. This person shall also be responsible for respect of the copyrights and will guaranty that the Products are not disseminated out of the
company.
7. Termination
7.1 If the Buyer cancels the order in whole or in part or postpones the date of mailing, the Buyer shall indemnify the Seller for the entire costs that
have been incurred as at the date of notification by the Buyer of such delay or cancellation. This may also apply for any other direct or indirect
consequential loss that may be borne by the Seller, following this decision.
7.2 In the event of breach by one Party under these conditions or the order, the non-breaching Party may send a notification to the other by recorded
delivery letter upon which, after a period of thirty (30) days without solving the problem, the non-breaching Party shall be entitled to terminate all the
pending orders, without being liable for any compensation.
8. Miscellaneous
All the provisions of these Terms and Conditions are for the benefit of the Seller itself, but also for its licensors, employees and agents. Each of them is
entitled to assert and enforce those provisions against the Buyer.
Any notices under these Terms and Conditions shall be given in writing. They shall be effective upon receipt by the other Party.
The Seller may, from time to time, update these Terms and Conditions and the Buyer, is deemed to have accepted the latest version of these terms
and conditions, provided they have been communicated to him in due time.
9. Governing law and jurisdiction
9.1 Any dispute arising out or linked to these Terms and Conditions or to any contract (orders) entered into in application of these Terms and
Conditions shall be settled by the French Commercial Courts of Grasse, which shall have exclusive jurisdiction upon such issues.
9.2 French law shall govern the relation between the Buyer and the Seller, in accordance with these Terms and Conditions.